Navigation Links
Progen in Medical News

Progen Receives Nasdaq Notice Regarding Board Composition

...ISBANE, Calif., April 22 /PRNewswire-FirstCall/ -- progen Pharmaceuticals Limited (ASX: PGL; Nasdaq: PGLA ...n during the 27th of March 2009 General Meeting of progen shareholders, as reported by the Company at the ti... fiscal year, which ends on the 30th of June 2009, progen intends to expand the board with independent direc...

Progen Technology Switches on Cancer Fighting Genes and Inhibits Tumor Growth

...epigenetics research and cancer therapeutics. progen CEO Justus Homburg said the latest findings reinfo...r silencing (switching off) of certain genes. progen and its collaborators have focused their research ...ns." In addition to its epigenetics findings, progen also presented an update on its cell proliferation...

Progen Investor Teleconference Dial In Details

...e contact Cindy Ingram on +61 7 3842 3333 or cindyi@progen- pharma.com and she will provide you with the appropriate toll free number. About Progen: progen Pharmaceuticals Limited is an Australia-based globally focused biotechnology company committed to the discovery, development and commercialization of ...

Progen Update on Phase 3 Clinical Program for PI-88 in Liver Cancer

... the assessment of delaying tumour recurrence following curative resection, progen is confident that its Phase 3 trial meets the FDA requirements for approval...and regulatory submissions have been filed in key countries. About Progen: progen Pharmaceuticals Limited is an Australian-based globally focused biotechnolo...

Progen to Present Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases

...vival. These results, combined with positive feedback from the FDA, provide progen with confidence in the potential of PI-88 for this indication and we are th... its development towards registration and commercialization. About Progen: progen Pharmaceuticals Limited is an Australia-based globally focused biotechnolog...

US FDA Fast Tracks PI-88 for the Treatment of Post Resection Liver Cancer

... BRISBANE, Sept. 24 /PRNewswire-FirstCall/ -- progen Pharmaceuticals Limited (ASX: PGL; Nasdaq: PGLA) a...dical need. The Fast Track designation will enable progen to file a New Drug Application (NDA) on a rolling ...n, in more than a dozen countries. About Progen: progen Pharmaceuticals Limited is an Australian-based glo...
Progen in Medical Technology

Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A

...continued the PI-88 phase 3 study in liver cancer. progen confirmed its strategic direction to develop its e...the phase 3 PATHWAY trial. The next step is that progen will seek expressions of interest in PI-88, at a r...ess than $4.0m. As part of the strategic review, progen has determined that the current phase 2b melanoma ...

Presentation of Data on Progen's Cancer Epigenetic Targets Platform

...g this novel therapeutic area", said Dr. Marton. progen already has preliminary preclinical efficacy data ...ranslational epigenetics research. About Progen: progen Pharmaceuticals is a globally focused biotechnolog...maceuticals primarily for the treatment of cancer. progen has built a focus and strength in anti-cancer drug...

Progen Resumes Phase 1 Development of Anti-Cancer Agent, PG-11047

...ly CGC-11047) for patients with advanced cancer. progen has commenced development of PG-11047 - the lead c...ce data within the next 12 months. About Progen: progen Pharmaceuticals is a globally focused biotechnolog...maceuticals primarily for the treatment of cancer. progen has operations in Australia and the US. About PG...

PG500 Series Presented at the AACR Annual Meeting in San Diego

...this calendar year, or early 2009. About Progen: progen Pharmaceuticals is a globally focused biotechnolog...maceuticals primarily for the treatment of cancer. progen has operations in Australia and the US. About the PG500 series: progen has an innovative small molecule Drug Discovery te...

Progen Announces Commencement of Global Phase 3 Study for PI-88 in Post- Resection Liver Cancer

...d Drug Administration (FDA). These results provide progen with confidence in the potential of PI-88 for this...obal regulatory filings for PI-88. About Progen: progen Pharmaceuticals is a globally focused biotechnolog...maceuticals primarily for the treatment of cancer. progen has operations in Australia and the US. ...

Preliminary PI-88 Phase 2 Prostate Cancer Results to be Presented at the American Society for Clinical Oncology (ASCO) 2008 Genitourinary Cancer Symposium

...nia in this phase 3 study, as it is a monotherapy study in a patient population with which we already have substantial clinical data." About Progen: progen Pharmaceuticals Limited is an Australian-based globally focused biotechnology company committed to the discovery, development and commercialization of...

Progen Provides Update on Phase 3 Clinical Program for PI-88 in Liver Cancer

...or registration strategy. At this point in time, progen has received regulatory approval to conduct the ph...d Drug Administration (FDA). These results provide progen with confidence in the potential of PI-88 for this...obal regulatory filings for PI-88. About Progen: progen Pharmaceuticals Limited is an Australia-based glob...

Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases

...vival. These results, combined with positive feedback from the FDA, provide progen with confidence in the potential of PI-88 for this indication and we are th... its development towards registration and commercialization. About Progen: progen Pharmaceuticals Limited is an Australia-based globally focused biotechnolog...

Progen Announces PI-88 Phase 2 Lung Cancer Results

... BRISBANE, Sept. 24 /PRNewswire-FirstCall/ -- progen Pharmaceuticals Limited (ASX: PGL; Nasdaq: PGLA) t...n the primary liver cancer trial." About Progen: progen Pharmaceuticals Limited is an Australian-based glo...erapeutics primarily for the treatment of cancer. progen Information: Justus Homburg ...

Progen Pharmaceuticals Announces Fiscal 2007 Financial Results

...gh various fundraising activities, which provides progen with additional working capital to fund the Phase...Alliance between the two companies, which provides progen with maximum flexibility and the opportunity to m... American Association of Cancer Research meeting. progen expects to submit an Investigational New Drug app...
Progen in Biological Technology

Cytopia Letter to Progen Shareholders

MELBOURNE, Australia, Feb. 25 /PRNewswire/ -- Cytopia Limited (ASX: CYT) has today circulated a letter and other materials to Progen Pharmaceuticals Limited (ASX: PGL) shareholders. The letter provides an update on the current shareholders requisitioned meeting scheduled for 27 March 2009 and prov...

Cytopia and Other Progen Shareholders Maintain Call for Meeting

MELBOURNE, Australia, Feb. 9 /PRNewswire/ -- Shareholders continue to support choice of cash back option and new Progen board Call by over 18% of Progen shareholders to combine general meetings Significant funding shortfall identified in the Progen merger proposa...

Progen Shareholders Call Meeting to Spill Progen Board and Offer Merger or Full Cash Back to Shareholders

MELBOURNE, Australia, Jan. 28 /PRNewswire/ -- Cytopia Ltd (ASX: CYT) has joined with other Progen Pharmaceuticals Ltd (ASX: PGL) shareholders to call a Progen general meeting to elect a new board, pursue a merger and enable the first full share buyback offer to Progen shareholders. Key resolu...

Progen Concedes Shareholder Requisitioned Meeting

... -- progen board; - finally accepts legitimate ca... 19 /PRNewswire-FirstCall/ -- A general meeting of progen Pharmaceuticals Ltd (ASX:PGL) shareholders was val...ary 28, 2009 by Cytopia Ltd (ASX:CYT) and 14 other progen shareholders. The resolutions sought to achieve tw...

Progen Restructures Manufacturing and Drug Discovery Divisions

... and the manufacture of drug development material. progen expects the transfer of PI-88 manufacture to occur in the next 12 to 18 months. progen will maintain the manufacturing facility with exis...rrent cash reserves for driving present and future progen lead compounds towards commercialization. In...

Progen Expands Board of Directors

... These additions and changes strengthen and focus the Board's expertise as progen embarks on its next stage of growth with the continued development and comm...the growth of its scientific and consulting business, and has served on the progen Board as non-executive director since 1999, prior to his most recent appoin...

Progen Expands Drug Development Pipeline Through Acquisition of CellGate

... compounds. As a result of this acquisition, progen will: -- expand its cancer-focused clinical deve... is becoming a well-defined target in oncology and progen is excited to be entering this new frontier of can...esents a minimally dilutive up-front investment by progen and allows us to continue expanding our product pi...

Progen Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference

... accessed on the Company's website at http://www.progen-pharma.com . A replay of the webcast will be available for 30 days thereafter. About Progen: progen Pharmaceuticals Limited is an Australian-based globally focused biotechnology company committed to the discovery, development and commercialisation of...
Other Tags
(Date:9/2/2014)... (PRWEB) September 02, 2014 Anti-aging ... products and services such as anti-wrinkle treatments and ... based treatments, and breast augmentation becoming much sought ... by U.S.-based market intelligence firm Transparency Market Research, ... products will grow to USD 191.7 billion by ...
(Date:9/2/2014)... CITY, GA (PRWEB) September 02, 2014 Last ... whole new level with the launch of a luxurious line ... to announce that the SEA ISLAND COTTON Socks are joining ... compression level, giving more people the comfort of natural cotton ... COTTON Socks, they are surprised to find socks as soft ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 Alliance Strategies ... and multi-channel email marketing is pleased to announce it ... Firearms & Freedom as well as ... represent more than one million concerned Americans who can ... , “We are honored to continue providing our ...
(Date:9/2/2014)... What happens when you are hospitalized, but your ... arrive at the office for follow-up care, but ... about your hospital stay? Missing or incomplete ... (PCPs) can contribute to poor experiences and lead ... study shows that implementing guidelines can improve hospitals, ...
(Date:9/2/2014)... health risks, including heart disease and diabetes, but University ... mitigate one often-overlooked risk: not buckling up in the ... Jacobson, a professor of computer science and of mathematics, ... a decrease in seatbelt usage. However, these effects can ... "Primary seatbelt laws lead to increased use of seatbelts," ...
Breaking Medicine News(10 mins):Health News:Global Anti-aging Market Research Report 2018 by Transparency Market Research 2Health News:Global Anti-aging Market Research Report 2018 by Transparency Market Research 3Health News:SIGVARIS’ Luxury Line of Compression Socks, SEA ISLAND COTTON, Now Available in Stronger Compression Level 2Health News:ASG Continues to Bring New Lists to Market 2Health News:ASG Continues to Bring New Lists to Market 3Health News:Can data motivate hospital leaders to improve care transitions? 2Health News:Seatbelt laws encourage obese drivers to buckle up 2
(Date:9/2/2014)... breast milk is considered the most ideal source ... played a critical role in the evolution and ... human milk contains a large number of bacterial ... phenomenon comes as no surprise to scientists and ... is considered to be the result of co-evolutionary ...
(Date:9/2/2014)... integrity? Tell the truth; everyone has a tipping point. We ... lie if the benefit is great enough. Now, scientists have ... that decision. , The result was published online this ... prefer to be honest, even if lying is beneficial," said ... at the Virginia Tech Carilion Research Institute , where ...
(Date:9/2/2014)... With their long, spiky legs and their propensity for ... stuff of nightmares. And now research from North Carolina ... spread into homes across the eastern United States. , ... or pose any kind of threat to humans," says ... State and lead author of a paper about the ...
Breaking Biology News(10 mins):Are human breast milk microbiome 'neutral'? 2Are human breast milk microbiome 'neutral'? 3Scientists find possible neurobiological basis for tradeoff between honesty, self-interest 2Scientists find possible neurobiological basis for tradeoff between honesty, self-interest 3Scientists find possible neurobiological basis for tradeoff between honesty, self-interest 4Researchers find Asian camel crickets now common in US homes 2
Other Contents